JS-K, a novel non-ionic diazeniumdiolate derivative, inhibits Hep 3B hepatoma cell growth and induces c-Jun phosphorylation via multiple MAP kinase pathways-Reference-Cited by-同舟云学术

JS-K, a novel non-ionic diazeniumdiolate derivative, inhibits Hep 3B hepatoma cell growth and induces c-Jun phosphorylation via multiple MAP kinase pathways

Published:2003-10-13 Issue:3 Volume:197 Page:426-434
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J. Cell. Physiol.

Author:

Ren Zhenggang,Kar Siddhartha,Wang Ziqiu,Wang Meifang,Saavedra Joseph E.,Carr Brian I.

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Reference44 articles.

1. Transient and sustained ERK phosphorylation and nuclear translocation in growth control

2. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation

3. Sodium Nitroprusside-Induced Mitochondrial Apoptotic Events in Insulin-Secreting RINm5F Cells Are Associated with MAP Kinases Activation

4. Analysis of Vasodilator Responses to Novel Nitric Oxide Donors in the Hindquarters Vascular Bed of the Cat

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of JS-K, a First-in-Class Arylated Diazeniumdiolate, for the Treatment of Cancer;Critical Reviews™ in Oncogenesis;2023

2. Fifty Years of Diazeniumdiolate Research: A Tribute to Dr. Larry K. Keefer;Critical Reviews™ in Oncogenesis;2023

3. Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy;Pharmacological Reviews;2022-09-30

4. O2-(2,4-dinitrophenyl) diazeniumdiolate derivative induces G2/M arrest via PTEN-mediated inhibition of PI3K/Akt pathway in hepatocellular carcinoma cells;Journal of Pharmacy and Pharmacology;2021-06-30

5. JNK signaling as a target for anticancer therapy;Pharmacological Reports;2021-03-12